- Home
- KYTX vs ITRG Comparison
KYTX vs ITRG Comparison
Compare KYTX & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYTX
- ITRG
- Stock Information
- Founded
- KYTX 2018
- ITRG 1997
- Country
- KYTX United States
- ITRG Canada
- Employees
- KYTX N/A
- ITRG N/A
- Industry
- KYTX
- ITRG Precious Metals
- Sector
- KYTX
- ITRG Basic Materials
- Exchange
- KYTX NYSE
- ITRG Nasdaq
- Market Cap
- KYTX 130.8M
- ITRG 156.9M
- IPO Year
- KYTX 2024
- ITRG N/A
- Fundamental
- Price
- KYTX $2.78
- ITRG $1.15
- Analyst Decision
- KYTX Buy
- ITRG Strong Buy
- Analyst Count
- KYTX 5
- ITRG 1
- Target Price
- KYTX $23.20
- ITRG $2.00
- AVG Volume (30 Days)
- KYTX 468.8K
- ITRG 449.2K
- Earning Date
- KYTX 03-04-2025
- ITRG 03-26-2025
- Dividend Yield
- KYTX N/A
- ITRG N/A
- EPS Growth
- KYTX N/A
- ITRG N/A
- EPS
- KYTX N/A
- ITRG N/A
- Revenue
- KYTX N/A
- ITRG N/A
- Revenue This Year
- KYTX N/A
- ITRG N/A
- Revenue Next Year
- KYTX N/A
- ITRG $69.44
- P/E Ratio
- KYTX N/A
- ITRG N/A
- Revenue Growth
- KYTX N/A
- ITRG N/A
- 52 Week Low
- KYTX $2.65
- ITRG $0.64
- 52 Week High
- KYTX $30.60
- ITRG $1.28
- Technical
- Relative Strength Index (RSI)
- KYTX 36.42
- ITRG 55.92
- Support Level
- KYTX $2.65
- ITRG $1.14
- Resistance Level
- KYTX $3.11
- ITRG $1.20
- Average True Range (ATR)
- KYTX 0.22
- ITRG 0.07
- MACD
- KYTX 0.01
- ITRG -0.00
- Stochastic Oscillator
- KYTX 17.88
- ITRG 50.00
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.